In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Top Cited Papers
- 8 October 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 323 (1), 264-268
- https://doi.org/10.1016/j.bbrc.2004.08.085
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by NiclosamideAntimicrobial Agents and Chemotherapy, 2004
- HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirusBiochemical and Biophysical Research Communications, 2004
- Role of interferons in the treatment of severe acute respiratory syndromeExpert Opinion on Biological Therapy, 2004
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- Proliferative growth of SARS coronavirus in Vero E6 cellsJournal of General Virology, 2003
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Mechanism of Enhancement of the Antiviral Action of Interferon Against Herpes Simplex Virus-1 by ChloroquineJournal of Interferon & Cytokine Research, 1996
- Inhibition of Human Immunodeficiency Virus Infectivity by ChloroquineAIDS Research and Human Retroviruses, 1990
- Chloroquine Treatment in Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1978